Pineapple Sets $100M Blockchain Bet to Fuel Financial Revolution

Pineapple Financial Inc. (NYSE American: PAPL), a fintech company, has announced the launch of a $100 million private placement to acquire INJ, the native token of Injective, a blockchain platform focused on financial infrastructure. This move positions Pineapple as the first publicly traded company to hold INJ tokens, marking a strategic alignment with blockchain-based finance. The company’s treasury strategy will use the funds to purchase and stake INJ, with the expectation of generating approximately 12% annual yield, among the highest available on major blockchain networks [1].

The investment into Injective follows a growing trend of institutional adoption of digital assets in traditional finance. Pineapple’s approach aligns with broader industry shifts, particularly in the tokenization of financial assets, which is estimated to be a multi-trillion-dollar market. The company's decision highlights its conviction that blockchain-based liquidity solutions will play a pivotal role in reshaping financial infrastructure, offering faster, more efficient, and transparent systems for capital flows [1].

The initiative has attracted participation from major players in both traditional and crypto finance, including FalconX, Monarq, Abraxas, Kraken, Blockchain.com, Canary Capital, and the Injective Foundation. This broad support underscores the confidence in Pineapple’s strategy and in Injective’s capabilities as a blockchain platform. The network has seen a surge in usage of over 1,000% year-to-date, with over $60 billion in transactions processed. The speed and cost-efficiency of Injective transactions further enhance its appeal as an institutional-grade blockchain [1].

Eric Chen, co-founder of Injective, emphasized the significance of the move, stating that the launch of Pineapple’s Injective digital asset treasury represents a "defining moment" for Injective and its ecosystem. He highlighted Injective’s role in bridging Wall Street with on-chain finance and its potential to drive the transformation of traditional financial systems into a more transparent and globally accessible model [1].

Pineapple’s CEO, Shubha Dasgupta, noted that the investment reflects the company’s belief in the transformative power of blockchain-based assets. By committing $100 million to INJ, Pineapple is demonstrating its vision for the future of finance, where digital rails enable broader access and innovation. The firm views the Injective token as a critical component in building a financial system that is both transparent and efficient [1].

The timing of the investment coincides with increased regulatory interest in blockchain-based financial instruments in the United States. The SEC is currently reviewing an application for a staked INJ ETF by Canary Capital, which has sparked further institutional interest in the token. This regulatory development, along with Pineapple’s investment, suggests a growing acceptance of digital assets within mainstream financial markets [2]. As the market continues to evolve, Pineapple’s strategic move may set a precedent for other publicly traded companies seeking to integrate blockchain into their financial strategies [2].

Source:

[1] Pineapple Financial Announces the Launch of $100M Injective Digital Asset Treasury Strategy Becoming the First Publicly Traded INJ Holder Worldwide (https://www.newsfilecorp.com/release/264735)

[2] Pineapple Financial Launches First Corporate Injective (INJ) Treasury Strategy (https://finance.yahoo.com/news/pineapple-financial-launches-first-corporate-013712269.html)

[3] Pineapple Financial launches $100M Injective treasury strategy (https://cryptobriefing.com/pineapple-financial-injective-100m-treasury/)